Join us for Endpoints 11 2025

The top 11 biotech startups — who will make the list?

Endpoints 11 returns to Boston’s State Room this September, and this year's lineup will reflect an industry in transition.

While biotech faces its toughest funding environment in years, the companies we're spotlighting have found ways to keep advancing their programs and hitting key milestones. These aren't the flashy unicorns of 2021 — they're the biotechs grinding through Phase 2 trials, closing strategic partnerships, and building the kind of sustainable operations that can weather market volatility.

The evening will feature a mix of fireside chats and editorial conversations — expect candid discussions about what it actually takes to succeed right now.

We’ll announce the winners live, recognizing the companies our team believes have the best shot at thriving in today’s reality.

Meet the future of biotech — join us.

Early bird rate — save $150 — limited in-person tickets
Can’t make it to the event? Virtual passes are available